• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚临床甲状腺功能障碍与心血管后果:令人警醒的警钟?

Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call?

机构信息

School of Medicine, Patras University, Patras, Greece.

Red Cross Hospital, Athens, Greece.

出版信息

Trends Cardiovasc Med. 2020 Feb;30(2):57-69. doi: 10.1016/j.tcm.2019.02.011. Epub 2019 Mar 5.

DOI:10.1016/j.tcm.2019.02.011
PMID:30871865
Abstract

Subclinical thyroid dysfunction (STD), presenting as subclinical hypothyroidism (SHypo) or subclinical hyperthyroidism (SHyper), defined as abnormal serum thyrotropin (TSH) and normal free thyroid hormones, is associated with increased cardiovascular (CV) risk and mortality. Depending on the degree of such dysfunction, atherosclerosis, coronary artery disease, heart failure and cardiac arrhythmias, predominantly atrial fibrillation, characterize both disorders and increase CV and total mortality compared to euthyroid persons. There are some differences in the mechanisms involved in the increased CV risk incurred by each type of STD, with more traditional CV risk factors clustered in SHypo than in SHyper, while the role of the TSH or its absence thereof, together with the respective, even subtle, changes incurred in thyroid hormone concentrations, seem to adversely influence the CV system in both types of STD. There is evidence that treatment of STD confers potential benefits by reducing CV events, however, no consensus has been reached due to lack of randomized controlled studies. Nevertheless, due to accumulating evidence from observational studies, many authorities agree that individuals with severe SHypo (TSH > 10 mIU/L) or grade 2 SHyper (TSH < 0.1 mIU/L) should receive treatment, mostly for the increased risk of CV morbidity and mortality. The evidence reviewed herein should alert and help the clinician to wake up to these two potentially alarming conditions of STD as they may confer serious CV complications, while their treatment appears quite beneficial.

摘要

亚临床甲状腺功能障碍(STD)表现为亚临床甲状腺功能减退症(SHypo)或亚临床甲状腺功能亢进症(SHyper),定义为血清促甲状腺激素(TSH)异常和游离甲状腺激素正常,与心血管(CV)风险增加和死亡率升高有关。根据这种功能障碍的程度,动脉粥样硬化、冠状动脉疾病、心力衰竭和心律失常,主要是心房颤动,这两种疾病都有特征,并与甲状腺功能正常的人相比,增加了 CV 和总死亡率。每种类型的 STD 导致 CV 风险增加的机制存在一些差异,SHypo 比 SHyper 中更聚集了更多传统的 CV 危险因素,而 TSH 或其缺乏以及各自的、甚至是微妙的甲状腺激素浓度变化似乎都对两种类型的 STD 的 CV 系统产生不利影响。有证据表明,治疗 STD 通过减少 CV 事件带来潜在益处,然而,由于缺乏随机对照研究,尚未达成共识。尽管如此,由于观察性研究的积累证据,许多权威机构都认为严重 SHypo(TSH>10mIU/L)或 2 级 SHyper(TSH<0.1mIU/L)的患者应该接受治疗,主要是因为 CV 发病率和死亡率增加的风险。本文综述的证据应该引起并帮助临床医生警惕这两种潜在的 STD 情况,因为它们可能导致严重的 CV 并发症,而它们的治疗似乎非常有益。

相似文献

1
Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call?亚临床甲状腺功能障碍与心血管后果:令人警醒的警钟?
Trends Cardiovasc Med. 2020 Feb;30(2):57-69. doi: 10.1016/j.tcm.2019.02.011. Epub 2019 Mar 5.
2
Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update.亚临床甲状腺功能障碍与心血管疾病:2016 年更新版
Eur Heart J. 2018 Feb 14;39(7):503-507. doi: 10.1093/eurheartj/ehx050.
3
Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.糖尿病血液透析患者的甲状腺功能、心血管事件和死亡率。
Am J Kidney Dis. 2014 Jun;63(6):988-96. doi: 10.1053/j.ajkd.2013.10.009. Epub 2013 Dec 4.
4
Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation.甲状腺功能在正常范围内、亚临床甲状腺功能减退与心房颤动风险
Circulation. 2017 Nov 28;136(22):2100-2116. doi: 10.1161/CIRCULATIONAHA.117.028753. Epub 2017 Oct 23.
5
Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study.老年人群中甲状腺功能障碍与静脉血栓栓塞症的相关性:一项前瞻性队列研究。
J Thromb Haemost. 2016 Apr;14(4):685-94. doi: 10.1111/jth.13276. Epub 2016 Mar 23.
6
Association Between Serum Thyrotropin Levels and Mortality Among Euthyroid Adults in the United States.美国甲状腺功能正常成年人血清促甲状腺激素水平与死亡率之间的关联。
Thyroid. 2016 Oct;26(10):1457-1465. doi: 10.1089/thy.2016.0156. Epub 2016 Sep 13.
7
Thyroid function and cardiovascular events in chronic kidney disease patients.慢性肾病患者的甲状腺功能与心血管事件
J Nephrol. 2017 Apr;30(2):235-242. doi: 10.1007/s40620-016-0300-y. Epub 2016 Apr 2.
8
Subclinical thyroid dysfunction is associated with adverse prognosis in heart failure patients with reduced ejection fraction.亚临床甲状腺功能障碍与射血分数降低的心力衰竭患者的不良预后相关。
BMC Cardiovasc Disord. 2019 Apr 4;19(1):83. doi: 10.1186/s12872-019-1055-x.
9
Effects of thyroid hormone on the cardiovascular system.甲状腺激素对心血管系统的影响。
Recent Prog Horm Res. 2004;59:31-50. doi: 10.1210/rp.59.1.31.
10
Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies.前瞻性队列研究中的亚临床甲状腺功能障碍与心血管结局
Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):4-12. doi: 10.2174/1871530311313010003.

引用本文的文献

1
Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study.2型糖尿病合并亚临床甲状腺功能减退患者10年心血管疾病风险的性别差异:一项横断面研究
Front Endocrinol (Lausanne). 2025 Jul 31;16:1635444. doi: 10.3389/fendo.2025.1635444. eCollection 2025.
2
Micro- and Nanoplastics as Disruptors of the Endocrine System-A Review of the Threats and Consequences Associated with Plastic Exposure.微塑料和纳米塑料对内分泌系统的干扰——塑料暴露相关威胁与后果综述
Int J Mol Sci. 2025 Jun 26;26(13):6156. doi: 10.3390/ijms26136156.
3
Gut microbiota alteration was related to subclinical hypothyroidism and dyslipidemia in mice.
肠道微生物群改变与小鼠亚临床甲状腺功能减退和血脂异常有关。
FASEB J. 2025 Mar 15;39(5):e70445. doi: 10.1096/fj.202402289RR.
4
Serum levels of thyroxine, thyroid-stimulating hormone, and anti-thyroid peroxidase antibodies and their association with anxiety in environmentally exposed populations in Kazakhstan.哈萨克斯坦环境暴露人群中甲状腺素、促甲状腺激素和抗甲状腺过氧化物酶抗体的血清水平及其与焦虑的关联。
Arch Toxicol. 2025 Feb;99(2):825-833. doi: 10.1007/s00204-024-03908-x. Epub 2025 Jan 12.
5
Association between atherosclerosis and the development of multi-organ pathologies.动脉粥样硬化与多器官病变发展之间的关联。
SAGE Open Med. 2024 Dec 23;12:20503121241310013. doi: 10.1177/20503121241310013. eCollection 2024.
6
Subclinical hypothyroidism: a new predictor of heart failure with improved ejection fraction in HFrEF patients.亚临床甲状腺功能减退:射血分数保留的心力衰竭(HFrEF)患者发生射血分数改善的心力衰竭的新预测指标。
Intern Emerg Med. 2025 Mar;20(2):481-488. doi: 10.1007/s11739-024-03827-w. Epub 2024 Dec 17.
7
Metabolic Syndrome, Thyroid Dysfunction, and Cardiovascular Risk: The Triptych of Evil.代谢综合征、甲状腺功能障碍与心血管风险:邪恶的三重奏。
Int J Mol Sci. 2024 Oct 2;25(19):10628. doi: 10.3390/ijms251910628.
8
Associations between cardiovascular health and low thyroid function among US adults: a population-based study.美国成年人中心血管健康与甲状腺功能低下之间的关联:一项基于人群的研究。
Front Endocrinol (Lausanne). 2024 Sep 27;15:1437386. doi: 10.3389/fendo.2024.1437386. eCollection 2024.
9
Current Strategies for Atrial Fibrillation Prevention and Management: Taming the Commonest Cardiac Arrhythmia.心房颤动预防与管理的当前策略:驯服最常见的心律失常
Curr Vasc Pharmacol. 2025;23(1):31-44. doi: 10.2174/0115701611317504240910113003.
10
Cardiac manifestations in hyperthyroidism.甲状腺功能亢进症的心脏表现。
Rev Cardiovasc Med. 2022 Apr 11;23(4):136. doi: 10.31083/j.rcm2304136. eCollection 2022 Apr.